Skip to main content

What Waters's latest 10-Q says: 7 signals

Waters filed its latest 10-Q with the SEC on Aug 11, 2026. It discusses acquisition completed, capex increase and legacy modernization.

Public (WAT)Biotechnology Research10,000+ employeeswaters.comLinkedIn

Filed
Aug 11, 2026
Filings
2
Signals
16

10-Q · latest 10

What Waters's 10-Q filings say

  1. 10-Q

    Filed · 7 signals

    SEC EDGAR
  2. 10-Q

    Filed · 9 signals

    SEC EDGAR

Showing 10 of 16 filing signals. The Signal API returns all of them.

Get them with one API call

Earnings calls

Waters earnings headlines

From earnings call transcripts (Signal API type earnings-transcripts).

Earnings call headlines
Call dateWhat the company said
Raised full-year revenue and earnings guidance, signaling strong financial health.The company increased its full-year 2025 sales growth forecast to a 7% midpoint and expects double-digit EPS growth. This strong financial performance and positive outlook indicate available budget and confidence in making new investments.
Actively planning integration for major acquisition of BD's Biosciences business.Waters is deep in integration planning for its combination with BD's Biosciences & Diagnostic Solutions business, closing in Q1 2026. This massive effort involves mobilizing 120+ leaders and multiple workstreams, creating significant opportunities for consulting, systems integration, and operational efficiency vendors.
Modernizing Empower platform with AI/ML and shifting to subscription modelA significant release cadence is planned for 2026 to evolve the core Empower software into a modern, cloud-native platform using AI/ML. The company is actively transitioning large pharma customers from perpetual licenses to a subscription model, signaling budget for cloud, AI, and customer success technologies.
New FDA guidance on biosimilars expected to increase demand for analytical testingThe FDA is proposing to reduce reliance on clinical studies for biosimilar approvals in favor of advanced analytical characterization. This regulatory shift creates a significant tailwind and budget driver for analytical instruments and compliant software workflows within their pharma customer base.
Investing in AI/ML and cloud to modernize flagship Empower software platform.Waters is evolving its core Empower informatics platform into a modern, cloud-native system using AI and machine learning. This strategic initiative aims to reduce manual work, minimize compliance risks, and enhance instrument uptime, signaling significant investment in data, AI, and cloud technologies.
Acknowledges customer pain from compliance risks due to human errorLeadership explicitly identified minimizing compliance risks from human error as a key value driver for its customers in QA/QC labs. This highlights a critical pain point that solutions focused on automation, data integrity, and error reduction can address.

Signal API · MCP

Track Waters with the Signal API

One POST /v1/companies/enrich call with waters.com returns Waters 10-Q signals (sec-10q), each with its source. Or ask Claude through MCP.

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"waters.com","signal_types":["sec-10q"],"limit":20}'

Same industry

Questions about Waters 10-Q

When did Waters file its latest 10-Q?
Waters filed its latest 10-Q on Aug 11, 2026. The one before it was filed on May 12, 2026.
What did Waters disclose in its latest 10-Q?
From the filing dated Aug 11, 2026: Waters spending $90M annually on post-acquisition Transitional Services Agreement for IT, HR, and Finance.
What did Waters say on its recent earnings calls?
Q3 FY2025: Raised full-year revenue and earnings guidance, signaling strong financial health. (dated Nov 4, 2025).
Where can I read Waters's 10-Q filing?
The full filing is on SEC EDGAR: https://www.sec.gov/Archives/edgar/data/1000697/000119312526344691/d170082d10q.htm. This page summarizes what the filing says and links to it.

Source. Quarterly reports (Form 10-Q) filed with the SEC. Every card links to the filing on EDGAR.

Method. Insights are extracted from the filing text and grouped by category. Numbers are quoted from the filing.

Data as of .

How this data is built →Get it from the Signal API →